Australia has achieved a historic milestone in public health: for the first time since 1982, a year has been recorded with zero new cases of cervical cancer among women under the age of 25. This achievement is not a statistical anomaly, but rather the result of systematically implemented preventive healthcare policies over decades. By introducing a universal Human Papillomavirus (HPV) vaccination program in 2007, the country laid the groundwork for a process aimed at the complete elimination of this oncological disease by 2035.
This progress is driven by high immunization coverage and the modernization of the screening system. More than 80% of adolescents in Australia are vaccinated, and since 2017, the traditional “Pap smear” has been replaced by more sensitive DNA testing. The introduction of the self-collection method was also a significant breakthrough, removing barriers for patients who avoided clinical procedures for various reasons. Healthcare experts predict that if the current trend continues, Australia will become the first country in the world to achieve cervical cancer-free status—defined as fewer than 4 cases per 100,000 women annually.
Despite the positive results observed in the younger generation, the burden of the disease remains critical in older age cohorts. In women who were at risk of HPV infection before the implementation of the vaccination program, the pathology is often diagnosed at late stages, which significantly complicates the treatment process and increases financial pressure on the healthcare system.
Furthermore, the universal goal of elimination is threatened by structural inequality. Due to socio-economic barriers, reaching target metrics in certain groups, including the indigenous Aboriginal population, is expected to be delayed by 12 years. This disproportion indicates that scientific innovations alone are not enough. A comprehensive social policy is essential to ensure equal access to healthcare services for all social groups.
Australia’s experience serves as an evidence-based model that confirms the effectiveness of an integrated vaccination and screening strategy. However, the global replication of this approach requires sustained financial and institutional support, especially in low- and middle-income countries. The global eradication of cervical cancer, alongside biomedical progress, demands the strengthening of healthcare system resilience and policies focused on social justice.
Source: bbc.com
